HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rebecca A Dumont Selected Research

Neurofibromatosis 1 (Neurofibromatosis Type I)

9/2012Correlation of the genotype of paragangliomas and pheochromocytomas with their metabolic phenotype on 3,4-dihydroxy-6-18F-fluoro-L-phenylalanin PET.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rebecca A Dumont Research Topics

Disease

14Neoplasms (Cancer)
01/2019 - 01/2005
2Neuroendocrine Tumors (Neuroendocrine Tumor)
04/2019 - 03/2017
2Meningioma (Meningiomas)
10/2016 - 02/2015
2Pheochromocytoma
09/2012 - 04/2009
2Papilloma (Papillomatosis)
05/2012 - 01/2005
1Infections
09/2019
1Thyroid Nodule (Nodule, Thyroid)
08/2019
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
04/2019
1Anaplastic Thyroid Carcinoma
01/2019
1Gastrinoma
01/2015
1Prostatic Neoplasms (Prostate Cancer)
05/2013
1Graft vs Host Disease (Graft-Versus-Host Disease)
04/2013
1von Hippel-Lindau Disease (von Hippel Lindau Disease)
09/2012
1Paraganglioma (Paragangliomas)
09/2012
1Neurofibromatosis 1 (Neurofibromatosis Type I)
09/2012
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2012
1Neoplasm Metastasis (Metastasis)
02/2009
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2006
1Osteosarcoma (Osteogenic Sarcoma)
01/2005

Drug/Important Bio-Agent (IBA)

3Biomarkers (Surrogate Marker)IBA
09/2019 - 04/2009
3IntegrinsIBA
04/2013 - 02/2009
2Radioisotopes (Radionuclides)IBA
08/2019 - 05/2013
2Somatostatin Receptors (Somatostatin Receptor)IBA
10/2016 - 02/2015
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
02/2015 - 01/2015
2edotreotide lutetium LU-177IBA
02/2015 - 01/2015
2fluorodopa F 18IBA
09/2012 - 04/2009
2Proteins (Proteins, Gene)FDA Link
05/2012 - 01/2005
2Peptides (Polypeptides)IBA
08/2011 - 02/2009
21,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
04/2009 - 02/2009
1Anti-Bacterial Agents (Antibiotics)IBA
09/2019
1Complement System Proteins (Complement)IBA
09/2019
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2019
1IodineIBA
01/2019
1Edotreotide (SMT 487)IBA
03/2017
1somatostatin receptor 2IBA
03/2017
1DOTA(0)-Tyr(3)- 177Lu-octreotideIBA
02/2015
1DOTA-Tyr(3)- 90Y-octreotideIBA
02/2015
1Bombesin Receptors (Bombesin Receptor)IBA
05/2013
1Sirolimus (Rapamycin)FDA Link
05/2013
1TOR Serine-Threonine KinasesIBA
05/2013
1Protein Kinases (Protein Kinase)IBA
05/2013
1Succinate Dehydrogenase (Fumarate Reductase)IBA
09/2012
1AntioxidantsIBA
05/2012
1aspartic acid glycine arginineIBA
08/2011
1Focal Adhesion Protein-Tyrosine KinasesIBA
04/2009
1Amino Acid Transport Systems (Amino Acid Transporter)IBA
04/2009
1Dasatinib (BMS 354825)FDA Link
04/2009
1src-Family KinasesIBA
04/2009
1Integrin alphaVbeta3IBA
02/2009
1Aspartic Acid (Aspartate)FDA Link
02/2009
1Arginine (L-Arginine)FDA Link
02/2009
1AcidsIBA
02/2009
1Glycine (Aminoacetic Acid)FDA LinkGeneric
02/2009
1ErbB Receptors (EGF Receptor)IBA
10/2006
1Phosphotransferases (Kinase)IBA
10/2006
1Glucose (Dextrose)FDA LinkGeneric
10/2006
1ChloridesIBA
01/2005
1Pharmaceutical PreparationsIBA
01/2005
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2005
1Tetracycline (Achromycin)FDA LinkGeneric
01/2005

Therapy/Procedure

8Therapeutics
04/2019 - 01/2005
2Aftercare (After-Treatment)
02/2015 - 05/2013
1Radiotherapy
05/2013
1Intravenous Injections
02/2009